Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 217

Similar articles for PubMed (Select 21945595)

1.

Design, synthesis and biological evaluation of 2-(substituted phenyl)thiazolidine-4-carboxylic acid derivatives as novel tyrosinase inhibitors.

Ha YM, Park YJ, Lee JY, Park D, Choi YJ, Lee EK, Kim JM, Kim JA, Park JY, Lee HJ, Moon HR, Chung HY.

Biochimie. 2012 Feb;94(2):533-40. doi: 10.1016/j.biochi.2011.09.002. Epub 2011 Sep 17.

PMID:
21945595
2.

Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitors.

Ha YM, Park YJ, Kim JA, Park D, Park JY, Lee HJ, Lee JY, Moon HR, Chung HY.

Eur J Med Chem. 2012 Mar;49:245-52. doi: 10.1016/j.ejmech.2012.01.019. Epub 2012 Jan 24.

PMID:
22301213
3.

Synthesis and preliminary in vitro biological evaluation of 5-chloro-2-(substituted phenyl)benzo[d]thiazole derivatives designed as novel antimelanogenesis agents.

Ha YM, Uehara Y, Park D, Jeong HO, Park JY, Park YJ, Lee JY, Lee HJ, Song YM, Moon HR, Chung HY.

Appl Biochem Biotechnol. 2012 Nov;168(6):1416-33. doi: 10.1007/s12010-012-9867-5. Epub 2012 Sep 12.

PMID:
22968587
4.

Synthesis and biological activity of hydroxy substituted phenyl-benzo[d]thiazole analogues for antityrosinase activity in B16 cells.

Ha YM, Park JY, Park YJ, Park D, Choi YJ, Kim JM, Lee EK, Han YK, Kim JA, Lee JY, Moon HR, Chung HY.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2445-9. doi: 10.1016/j.bmcl.2011.02.064. Epub 2011 Feb 23.

PMID:
21397499
5.

Design, synthesis, and evaluation of (E)-N-substituted benzylidene-aniline derivatives as tyrosinase inhibitors.

Bae SJ, Ha YM, Park YJ, Park JY, Song YM, Ha TK, Chun P, Moon HR, Chung HY.

Eur J Med Chem. 2012 Nov;57:383-90. doi: 10.1016/j.ejmech.2012.09.026. Epub 2012 Sep 23.

PMID:
23149255
6.

Characterization of a novel tyrosinase inhibitor, (2RS,4R)-2-(2,4-dihydroxyphenyl)thiazolidine-4-carboxylic acid (MHY384).

Han YK, Park YJ, Ha YM, Park D, Lee JY, Lee N, Yoon JH, Moon HR, Chung HY.

Biochim Biophys Acta. 2012 Apr;1820(4):542-9. doi: 10.1016/j.bbagen.2012.01.001. Epub 2012 Jan 9.

PMID:
22251576
7.

Structural requirement of phenylthiourea analogs for their inhibitory activity of melanogenesis and tyrosinase.

Thanigaimalai P, Lee KC, Sharma VK, Joo C, Cho WJ, Roh E, Kim Y, Jung SH.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6824-8. doi: 10.1016/j.bmcl.2011.09.024. Epub 2011 Sep 13.

PMID:
21978680
8.

Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors.

Bandgar BP, Adsul LK, Chavan HV, Shringare SN, Korbad BL, Jalde SS, Lonikar SV, Nile SH, Shirfule AL.

Bioorg Med Chem. 2012 Sep 15;20(18):5649-57. doi: 10.1016/j.bmc.2012.07.001. Epub 2012 Jul 10.

PMID:
22901670
9.

Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4 dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP).

Chung KW, Park YJ, Choi YJ, Park MH, Ha YM, Uehara Y, Yoon JH, Chun P, Moon HR, Chung HY.

Biochim Biophys Acta. 2012 Jul;1820(7):962-9. doi: 10.1016/j.bbagen.2012.03.018. Epub 2012 Apr 3.

PMID:
22498140
10.

4-(6-Hydroxy-2-naphthyl)-1,3-bezendiol: a potent, new tyrosinase inhibitor.

Ha YM, Chung SW, Song S, Lee H, Suh H, Chung HY.

Biol Pharm Bull. 2007 Sep;30(9):1711-5.

11.
12.

Evaluation of the inhibition of mushroom tyrosinase and cellular tyrosinase activities of oxyresveratrol: comparison with mulberroside A.

Kim JK, Park KT, Lee HS, Kim M, Lim YH.

J Enzyme Inhib Med Chem. 2012 Aug;27(4):495-503. doi: 10.3109/14756366.2011.598866. Epub 2011 Aug 10.

PMID:
21827364
13.

Inhibitory effects of 6-(3-hydroxyphenyl)-2-naphthol on tyrosinase activity and melanin synthesis.

Chung SW, Ha YM, Kim YJ, Song S, Lee H, Suh H, Chung HY.

Arch Pharm Res. 2009 Feb;32(2):289-94. doi: 10.1007/s12272-009-1235-9. Epub 2009 Mar 13.

PMID:
19280161
14.

Resveratrol as a kcat type inhibitor for tyrosinase: potentiated melanogenesis inhibitor.

Satooka H, Kubo I.

Bioorg Med Chem. 2012 Jan 15;20(2):1090-9. doi: 10.1016/j.bmc.2011.11.030. Epub 2011 Dec 3.

PMID:
22189272
15.

Inhibitory effects of Sargassum polycystum on tyrosinase activity and melanin formation in B16F10 murine melanoma cells.

Chan YY, Kim KH, Cheah SH.

J Ethnopharmacol. 2011 Oct 11;137(3):1183-8. doi: 10.1016/j.jep.2011.07.050. Epub 2011 Jul 26.

PMID:
21810462
16.
17.

A novel synthesized tyrosinase inhibitor: (E)-2-((2,4-dihydroxyphenyl)diazenyl)phenyl 4-methylbenzenesulfonate as an azo-resveratrol analog.

Bae SJ, Ha YM, Kim JA, Park JY, Ha TK, Park D, Chun P, Park NH, Moon HR, Chung HY.

Biosci Biotechnol Biochem. 2013;77(1):65-72. Epub 2013 Jan 7.

18.

Analogs of 5-(substituted benzylidene)hydantoin as inhibitors of tyrosinase and melanin formation.

Ha YM, Kim JA, Park YJ, Park D, Kim JM, Chung KW, Lee EK, Park JY, Lee JY, Lee HJ, Yoon JH, Moon HR, Chung HY.

Biochim Biophys Acta. 2011 Jun;1810(6):612-9. doi: 10.1016/j.bbagen.2011.03.001. Epub 2011 Mar 21.

PMID:
21397665
19.

1-(2,4-dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a novel tyrosinase inhibitor with strong depigmenting effects.

Nesterov A, Zhao J, Minter D, Hertel C, Ma W, Abeysinghe P, Hong M, Jia Q.

Chem Pharm Bull (Tokyo). 2008 Sep;56(9):1292-6.

20.

A newly synthesized, potent tyrosinase inhibitor: 5-(6-hydroxy-2-naphthyl)-1,2,3-benzenetriol.

Choi J, Bae SJ, Ha YM, No JK, Lee EK, Lee JS, Song S, Lee H, Suh H, Yu BP, Chung HY.

Bioorg Med Chem Lett. 2010 Aug 15;20(16):4882-4. doi: 10.1016/j.bmcl.2010.06.087. Epub 2010 Jun 19. Erratum in: Bioorg Med Chem Lett. 2011 Jan 1;21(1):606.

PMID:
20619644
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk